Penn Medicine and Wills Eye Hospital Have Agreed to Partner

The two Philadelphia institutions have signed a preliminary agreement to form a new ophthalmology partnership.

Updated on Oct. 9, 2026 in Healthcare

Penn Medicine and Wills Eye Hospital Have Agreed to Partner

Live Poll

Do you believe hospital partnerships and mergers are generally good for your local community?

Wills Eye Hospital and Penn Medicine have announced a preliminary joint operating agreement following Wills Eye Hospital ending its longtime affiliation with Jefferson Health. The two entities are currently conducting due diligence to explore collaboration in research, training, and clinical care.

Why it matters

The move aims to address ongoing financial difficulties at Wills Eye Hospital, which has recorded 11 consecutive years of operating losses. This partnership represents a significant realignment of Philadelphia’s specialized eye-care services.

Wills Eye Hospital reported a $15.9 million operating loss on $109.8 million in annual revenue for the fiscal year ending June 30, 2025. The hospital continues to operate a 4-bed inpatient unit at its 840 Walnut Street facility.

The players

Wills Eye Hospital

This Philadelphia-based medical institution provides specialized ophthalmological care and has operated since 1832.

Penn Medicine

This is a major academic health system based in Philadelphia that operates hospitals and research facilities.

Jefferson Health

This large healthcare system recently ended its multi-decade affiliation with Wills Eye Hospital.

Julia A. Haller

She serves as the CEO of Wills Eye Hospital and informed staff about the shift in hospital partnerships.

Robert Sergott

He was appointed as the interim chair of ophthalmology at Sidney Kimmel Medical College by Jefferson Health.

The details

The partnership is expected to explore opportunities for integrated patient care, research, and educational initiatives. While the deal is in early stages, Jefferson Health has already moved to restructure its own program by appointing new leadership.

Wills Eye Hospital was founded in 1832.
The hospital began its affiliation with Thomas Jefferson University Hospital in 1972.
The fiscal year ending June 30, 2025, marked the period for the most recent financial reports.
Wills CEO Julia A. Haller notified employees of the new deal between October 6 and 10, 2026.
Jefferson appointed Robert Sergott as interim chair of ophthalmology on October 8, 2026.

Market Landscape

The transition away from the 1972 affiliation agreement between Wills and Jefferson marks a complete departure from the long-standing model for local eye-care delivery. This deal reshapes the competitive landscape for specialty medical services in Philadelphia.

Patients currently utilizing the inpatient services at 840 Walnut Street may see changes to clinical protocols as the transition moves forward. The shift in organizational leadership at Jefferson may also affect ongoing training programs and patient access within their network.

The takeaway

The proposed partnership reflects a major effort to stabilize the finances of a historic medical institution facing long-term deficits. Patients should monitor future announcements regarding how these clinical changes will impact their care options.